These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15596596)

  • 1. Bilateral conjunctival nodules: an unusual manifestation of Vogt-Koyanagi-Harada syndrome.
    Yang MC; Huang AJ
    Arch Ophthalmol; 2004 Dec; 122(12):1878-81. PubMed ID: 15596596
    [No Abstract]   [Full Text] [Related]  

  • 2. Bilateral disc edema in a patient with Vogt-Koyanagi-Harada disease.
    Yang HK; Park KH; Kim JS; Hwang JM
    Can J Ophthalmol; 2014 Apr; 49(2):e54-6. PubMed ID: 24767242
    [No Abstract]   [Full Text] [Related]  

  • 3. Conjunctival nodules associated with Vogt-Koyanagi-Harada disease.
    Nakao K; Shimonagano Y; Doi N; Sakamoto T
    Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1383-6. PubMed ID: 17701198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vogt-Koyanagi-Harada syndrome in an 11-year-old Boy.
    Ikeda N; Hayasaka S; Kadoi C; Nagaki Y
    Ophthalmologica; 1999; 213(3):197-9. PubMed ID: 10202295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Vogt-Koyanagi-Harada syndrome in pregnancy.
    Tien MC; Teoh SC
    Can J Ophthalmol; 2009 Apr; 44(2):211-2. PubMed ID: 19491962
    [No Abstract]   [Full Text] [Related]  

  • 6. Late posterior segment relapses in a series of Vogt-Koyanagi-Harada disease.
    Errera MH; Levinson RD; Fardeau C; Thomas D; Cohen D; Navarro A; Héron E; Paques M; Pavesio C; Sahel JA; Westcott MC; Gaudric A; LeHoang P; Bodaghi B
    Acta Ophthalmol; 2015 Sep; 93(6):e509-10. PubMed ID: 25604241
    [No Abstract]   [Full Text] [Related]  

  • 7. Vogt-Koyanagi-Harada disease in 3-year-old boy.
    Takada S; Tanaka R; Kurita N; Ishii K; Kaburaki T
    Clin Exp Ophthalmol; 2015 Aug; 43(6):593-4. PubMed ID: 25711345
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease.
    Errera MH; Fardeau C; Cohen D; Navarro A; Gaudric A; Bodaghi B; Westcott M; LeHoang P
    Acta Ophthalmol; 2011 Jun; 89(4):e357-66. PubMed ID: 21251241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular brucellosis vs Vogt-Koyanagi-Harada syndrome.
    Goldstein DA; Tessler HH
    Arch Ophthalmol; 2006 Apr; 124(4):608-9; author reply 609. PubMed ID: 16606901
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recurrent uveitis with bilateral exudative retinal detachment. 10-year-old boy with bilaterally impaired vision and eye pain. Vogt-Koyanagi-Harada syndrome].
    Kohnen EM; Pansdorf Y; Zubcov A
    Ophthalmologe; 2004 Apr; 101(4):390-3. PubMed ID: 15067421
    [No Abstract]   [Full Text] [Related]  

  • 11. Vogt-Koyanagi-Harada syndrome in a 4-year-old child.
    Gruich MJ; Evans OB; Storey JM; Bradley ST; Chen CJ
    Pediatr Neurol; 1995 Jul; 13(1):50-1. PubMed ID: 7575849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual case of vitiligo reversal in Vogt-Koyanagi-Harada syndrome.
    Subudhi P; Khan Z; Subudhi BNR; Sitaram S
    Indian J Ophthalmol; 2017 Sep; 65(9):867-868. PubMed ID: 28905833
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vogt-Koyanagi-Harada disease].
    Kjeka O; Krohn J
    Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2195-7. PubMed ID: 16138134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
    Hashizume K; Imamura Y; Fujiwara T; Machida S; Ishida M; Kurosaka D
    Retina; 2016 Feb; 36(2):415-21. PubMed ID: 26352553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vogt-Koyanagi-Harada syndrome in two patients with immunoglobulin A nephropathy.
    Matsuo T; Masuda I; Ota K; Yamadori I; Sunami R; Nose S
    Acta Med Okayama; 2007 Oct; 61(5):305-9. PubMed ID: 17971847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals.
    Iwahashi C; Okuno K; Hashida N; Nakai K; Ohguro N; Nishida K
    Jpn J Ophthalmol; 2015 May; 59(3):157-63. PubMed ID: 25808016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vogt-Koyanagi-Harada Syndrome in a Group of Patients in Two Ophthalmology Referral Centers in Bogotá, Colombia.
    Guayacán CL; Galindo-Mendez B; de-la-Torre A
    Ocul Immunol Inflamm; 2018; 26(7):1123-1127. PubMed ID: 28910557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutton fat-like subretinal precipitates associated with Vogt-Koyanagi-Harada disease.
    Hamabata K; Hashizume K; Ishikawa Y; Fujiwara T; Machida S; Kurosaka D
    Ocul Immunol Inflamm; 2010 Jan; 18(1):44-5. PubMed ID: 20128649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
    Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
    Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vogt-Koyanagi-Harada Syndrome following influenza vaccination.
    Kim M
    Indian J Ophthalmol; 2016 Jan; 64(1):98. PubMed ID: 26953036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.